Literature DB >> 27824831

Myriad's impact on gene patents.

Mateo Aboy1,2, Kathleen Liddell1, Johnathon Liddicoat1, Cristina Crespo1.   

Abstract

Mesh：

Year:  2016        PMID： 27824831     DOI： 10.1038/nbt.3719

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  14 in total

1.  Biotechnology patents under fire.

Authors:  Irena Royzman
Journal:  Nat Biotechnol       Date:  2015-09       Impact factor: 54.908

Review 2.  The History of Patenting Genetic Material.

Authors:  Jacob S Sherkow; Henry T Greely
Journal:  Annu Rev Genet       Date:  2015-10-06       Impact factor: 16.830

3.  AMP v. Myriad: a surgical strike on Blockbuster business models.

Authors:  Richard E Gold; Robert Cook-Deegan; Tania Bubela
Journal:  Sci Transl Med       Date:  2013-07-03       Impact factor: 17.956

4.  Myriad decision aftershocks ripple through biotech.

Authors:  Mark Ratner
Journal:  Nat Biotechnol       Date:  2013-08       Impact factor: 54.908

Review 5.  The impact of Myriad and Mayo: will advancements in the biological sciences be spurred or disincentivized? (Or was biotech patenting not complicated enough?).

Authors:  Jennifer Gordon
Journal:  Cold Spring Harb Perspect Med       Date:  2014-12-11       Impact factor: 6.915

6.  Patent landscaping for life sciences innovation: toward consistent and transparent practices.

Authors:  Tania Bubela; E Richard Gold; Gregory D Graff; Daniel R Cahoy; Dianne Nicol; David Castle
Journal:  Nat Biotechnol       Date:  2013-03       Impact factor: 54.908

Review 7.  Patents in genomics and human genetics.

Authors:  Robert Cook-Deegan; Christopher Heaney
Journal:  Annu Rev Genomics Hum Genet       Date:  2010       Impact factor: 8.929

8.  Gene patents and personalized cancer care: impact of the Myriad case on clinical oncology.

Authors:  Kenneth Offit; Angela Bradbury; Courtney Storm; Jon F Merz; Kevin E Noonan; Rebecca Spence
Journal:  J Clin Oncol       Date:  2013-06-13       Impact factor: 44.544

9.  Persistent confusion and controversy surrounding gene patents.

Authors:  Christi J Guerrini; Mary A Majumder; Amy L McGuire
Journal:  Nat Biotechnol       Date:  2016-02       Impact factor: 54.908

10.  Dolly and Alice.

Authors:  Dan L Burk
Journal:  J Law Biosci       Date:  2015-10-16
View more
  4 in total

1.  Was the Myriad decision a 'surgical strike' on isolated DNA patents, or does it have wider impacts?

Authors:  Mateo Aboy; Cristina Crespo; Kathleen Liddell; Johnathon Liddicoat; Matthew Jordan
Journal:  Nat Biotechnol       Date:  2018-12-06       Impact factor: 54.908

2.  After Myriad, what makes a gene patent claim 'markedly different' from nature?

Authors:  Mateo Aboy; Johnathon Liddicoat; Kathleen Liddell; Matthew Jordan; Cristina Crespo
Journal:  Nat Biotechnol       Date:  2017-09-11       Impact factor: 54.908

3.  European patent protection for medical uses of known products and drug repurposing.

Authors:  Mateo Aboy; Kathleen Liddell; Matthew Jordan; Cristina Crespo; Johnathon Liddicoat
Journal:  Nat Biotechnol       Date:  2022-04       Impact factor: 54.908

4.  Gene patents still alive and kicking: their impact on provision of genetic testing for long QT syndrome in the Canadian public health-care system.

Authors:  Sarah E Ali-Khan; E Richard Gold
Journal:  Genet Med       Date:  2017-05-11       Impact factor: 8.822
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.